SOTERA HEALTH COMPANY Capital Expenditures
SOTERA HEALTH COMPANY (SHC) reported Capital Expenditures of $92.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $46.45M, a 48.74% increase year-over-year.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $46.17M, a 131.78% increase year-over-year.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $50.70M, a 23.03% decline year-over-year.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $36.17M, a 0.60% decline year-over-year.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for fiscal 2025 was $138.02M, a 22.93% decline from fiscal 2024.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for fiscal 2024 was $179.07M, a 16.70% decline from fiscal 2023.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for fiscal 2023 was $214.97M, a 17.87% increase from fiscal 2022.
- SOTERA HEALTH COMPANY payments to acquire property, plant, and equipment for fiscal 2022 was $182.38M, a 78.52% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $46.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $92.61M 10-Q · filed 2026-08-06 | $143.31M derived: sum of 3 quarters · filed 2026-08-06 | $179.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $46.17M 10-Q · filed 2026-05-05 | $96.86M derived: sum of 2 quarters · filed 2026-05-05 | $133.04M derived: sum of 3 quarters · filed 2026-05-05 | $164.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $50.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $86.87M derived: sum of 2 quarters · filed 2026-02-24 | $118.10M derived: sum of 3 quarters · filed 2026-08-06 | $138.02M 10-K · filed 2026-02-24 |
| 2025-09-30 | $36.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $67.40M derived: sum of 2 quarters · filed 2026-08-06 | $87.32M 10-Q · filed 2025-11-04 | $153.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $31.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $51.15M 10-Q · filed 2026-08-06 | $117.02M derived: sum of 3 quarters · filed 2026-08-06 | $153.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $19.92M 10-Q · filed 2026-05-05 | $85.79M derived: sum of 2 quarters · filed 2026-05-05 | $122.18M derived: sum of 3 quarters · filed 2026-05-05 | $164.10M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $65.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $102.26M derived: sum of 2 quarters · filed 2026-02-24 | $144.18M derived: sum of 3 quarters · filed 2026-02-24 | $179.07M 10-K · filed 2026-02-24 |
| 2024-09-30 | $36.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $78.31M derived: sum of 2 quarters · filed 2025-11-04 | $113.20M 10-Q · filed 2025-11-04 | $178.03M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $41.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $76.81M 10-Q · filed 2025-08-08 | $141.64M derived: sum of 3 quarters · filed 2026-02-24 | $193.65M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $34.89M 10-Q · filed 2025-05-01 | $99.72M derived: sum of 2 quarters · filed 2026-02-24 | $151.73M derived: sum of 3 quarters · filed 2026-02-24 | $204.87M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $64.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $116.84M derived: sum of 2 quarters · filed 2026-02-24 | $169.97M derived: sum of 3 quarters · filed 2026-02-24 | $214.97M 10-K · filed 2026-02-24 |
| 2023-09-30 | $52.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $105.15M derived: sum of 2 quarters · filed 2024-11-05 | $150.15M 10-Q · filed 2024-11-05 | $221.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $53.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $98.13M 10-Q · filed 2024-08-05 | $169.87M derived: sum of 3 quarters · filed 2025-02-27 | $208.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $45.00M 10-Q · filed 2024-05-02 | $116.74M derived: sum of 2 quarters · filed 2025-02-27 | $155.74M derived: sum of 3 quarters · filed 2025-02-27 | $191.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $71.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $110.74M derived: sum of 2 quarters · filed 2025-02-27 | $146.83M derived: sum of 3 quarters · filed 2025-02-27 | $182.38M 10-K · filed 2025-02-27 |
| 2022-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $75.10M derived: sum of 2 quarters · filed 2023-11-01 | $110.64M 10-Q · filed 2023-11-01 | $151.91M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $36.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $71.64M 10-Q · filed 2023-08-03 | $112.91M derived: sum of 3 quarters · filed 2024-02-27 | $129.01M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $35.55M 10-Q · filed 2023-05-03 | $76.81M derived: sum of 2 quarters · filed 2024-02-27 | $92.92M derived: sum of 3 quarters · filed 2024-02-27 | $116.77M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $41.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $57.37M derived: sum of 2 quarters · filed 2024-02-27 | $81.22M derived: sum of 3 quarters · filed 2024-02-27 | $102.16M 10-K · filed 2024-02-27 |
| 2021-09-30 | $16.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $39.96M derived: sum of 2 quarters · filed 2022-11-02 | $60.90M 10-Q · filed 2022-11-02 | $80.77M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $23.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $44.79M 10-Q · filed 2022-08-04 | $64.66M derived: sum of 3 quarters · filed 2023-02-28 | $74.86M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $20.94M 10-Q · filed 2022-05-05 | $40.81M derived: sum of 2 quarters · filed 2023-02-28 | $51.01M derived: sum of 3 quarters · filed 2023-02-28 | $61.46M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $19.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $30.07M derived: sum of 2 quarters · filed 2023-02-28 | $40.52M derived: sum of 3 quarters · filed 2023-02-28 | $53.51M 10-K · filed 2023-02-28 |
| 2020-09-30 | $10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $20.65M derived: sum of 2 quarters · filed 2021-11-10 | $33.64M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $10.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $23.44M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $12.99M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $57.26M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |